Berger Dietmar 4
4 · GILEAD SCIENCES, INC. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Berger Dietmar
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-02+16,326→ 16,326 total - Tax Payment
Common Stock
2026-01-02$121.60/sh−6,944$844,390→ 9,382 total - Exercise/Conversion
Restricted Stock Unit
2026-01-02−16,326→ 41,179 total→ Common Stock (16,326 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units vest in approximately three equal installments on the first three anniversaries of the date of grant until fully vested.